(Q33545590)

27 July 2017

1 reference

title

Hypertension in the elderly with coexisting benign prostatic hyperplasia (English)

1 reference

27 July 2017

main subject

arterial hypertension

0 references

author name string

Maruenda J

series ordinal

1

1 reference

27 July 2017

Bhatnagar V

series ordinal

2

1 reference

27 July 2017

Lowenthal DT

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

53

1 reference

27 July 2017

issue

3 Suppl 3a

1 reference

27 July 2017

page(s)

7-12; discussion 12-3, 41-2

1 reference

Epidemiology and prevention of hypertension

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Epidemiology of Bladder Emptying Symptoms in Elderly Men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Doxazosin for benign prostatic hyperplasia in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Renal function in aging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Connective tissue protein in the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Alteration of collagen biosynthesis and analysis of type I and type III collagens of prostate in young rats following sex hormone treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Benign prostatic hyperplasia: diagnosis and treatment guideline.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Calcium antagonists. Their physiological differences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Calcium channel blockers. Consensus amid controversy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Angiotensin II receptor inhibition. A new therapeutic principle

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Role of α1-and α2-adrenoceptors in the modulation of the baroreflex vagal bradycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Current status of diuretics, beta-blockers, alpha-blockers, and alpha-beta-blockers in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Alpha1-adrenoceptor subtypes in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Tamsulosin : A Review of its Pharmacological Properties and Therapeutic Potential in the Management of Symptomatic Benign Prostatic Hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: pharmacodynamic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900533-0

7 January 2021

10.1016/S0090-4295(98)00533-0

Identifiers

DOI

1 reference

27 July 2017

1 reference